Biochemistry, Genetics and Molecular Biology
Drug Screening
50%
Autophagy
50%
Epidermal Growth Factor Receptor
50%
Mouse Model
50%
Ciliary Neurotrophic Factor
50%
Genetics
38%
IDH1
33%
Vascularization
16%
Platelet Derived Growth Factor Receptor Alpha
16%
Clinical Trial
16%
Epigenetics
16%
Alpha Thalassemia/Mental Retardation X-Linked
16%
Clonal Evolution
16%
Promoter Region
16%
Drug Response
16%
Transcriptomics
16%
Cyclin-Dependent Kinase
16%
Cancer Model
16%
Cyclin Dependent Kinase Inhibitor 2A
16%
Bevacizumab
11%
Amyloid Protein
6%
Preclinical Study
6%
Janus Kinase
6%
Transcription
6%
Nerve Cell Degeneration
6%
Neurotrophic Factor
6%
Alginate
6%
Ex Vivo Gene Transfer
6%
Secretion (Process)
6%
Ciliary Neurotrophic Factor Receptor
6%
Gene Expression Profiling
5%
Tumor Progression
5%
Keyphrases
Alzheimer's Disease Model
50%
Synaptic Dysfunction
50%
Ciliary Neurotrophic Factor
50%
Orthotopic Xenograft
50%
Patient-derived Organoids
50%
Health Avatar
50%
ATG9A
50%
Organoid Culture
16%
Preclinical Tool
16%
Tumor Organoids
16%
Drug Testing
16%
Cyclin-dependent Kinase 4 (CDK4)
16%
High-throughput Drug Screen
8%
Personalized Treatment
8%
Long-range Propagation
8%
Bifunctional Alkylating Agent
8%
Survival Pathways
6%
Cognitive Function
6%
Recombinant Cells
6%
Synaptic Degeneration
6%
Tg2576
6%
Locoregional
6%
Neurotrophic Factors
6%
Regional Delivery
6%
Memory Deficits
6%
Synaptic Connectivity
6%
Neuronal Survival
6%
Synaptic Proteins
6%
Alginate Polymer
6%
Ciliary Neurotrophic Factor Receptor
6%
Effective Dose
5%
Negatively Associated
5%
Genetic Interference
5%
Atg9
5%
Induced Activation
5%
Medicine and Dentistry
Organoid
100%
Ganglioglioma
100%
Xenograft
100%
Neoplasm
62%
Epidermal Growth Factor Receptor
18%
Cancer Research
12%
Temozolomide
12%
Drug Screening
12%
Clinical Trial
6%
Targeted Therapy
6%
Combination Therapy
6%
Glioblastoma
6%
Cancer Model
6%
Tumor Biology
6%
Promoter Region
6%
Translational Research
6%
Transcriptomics
6%
Alkylating Antineoplastic Agent
6%
Tumor Recurrence
6%
Vascularity
6%
Personalized Medicine
6%
Primary Tumor
6%
Drug Response
6%
CDK4/6 Inhibitor
6%
Cyclin-Dependent Kinase
6%
Cyclin Dependent Kinase Inhibitor 2A
6%
